Drugmaker Reinvents Itself And Expands Footprint Internationally
Winston Churchill once said, "There is nothing wrong with change, if it is in the right direction." ICN Pharmaceuticals lacked focus and direction following the resignation of its founder Milan Panic in 2002. The company was a mess with sinking sales, the loss of two key patents and a bunch of divisions with little in common and no clear strategy. It was time to change. In November 2003, the drugmaker renamed itself Valeant Pharmaceuticals (VRX)
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here